Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial ...

The head of the FDA’s artificial intelligence-focused Digital Center of Excellence, Troy Tazbaz, is departing the agency, ...

Dr. Sara Brenner, who has been FDA CDRH's in vitro diagnostics chief medical officer, is serving as acting commissioner of the agency.

The FDA says the cybersecurity vulnerabilities identified may put patients at risk when the device is connected to the internet.

Among the wave of guidance documents issued by the U.S. Food and Drug Administration (“FDA” or the “Agency”) in the first week of 2025 were ...

WASHINGTON, D.C. — The Food and Drug Administration (FDA) has launched a national search for a new Director for the Center ...

The website changes raise concerns about “the interference of politics with the study and the practice” of science and ...

The FDA is urging Congress to implement mandatory medical device shortage reporting to address growing vulnerabilities in the ...

The FDA is particularly concerned that supply chain issues are having an adverse impact on neonatal and paediatric patients.

AI is touching every industry, and healthcare is no exception: the global market size for healthcare AI, which was valued at ...

While medical device shortages are nothing new, the FDA said it is becoming more concerned that supply chain disruptions are ...

leaving the FDA unable to act proactively to avert device shortages. “In many of these circumstances, neonatal and pediatric devices have been the most impacted,” Tarver added. The CDRH director ...